Europe: Court awards compensation to Acteon for nullity proceedings
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Europe: Court awards compensation to Acteon for nullity proceedings

In a recent ruling by the Court of The Hague (ECLI:NL:RBDHA:2018: 4591) a defendant/patentee has been ordered to pay the costs of nullity proceedings brought against it, despite not wishing to maintain or assert its patent.

Following infringement proceedings instituted in Germany by Dürr Dental based on European patent EP 1 9292 371 B1 against Acteon, the latter company, active in the same field, started nullity proceedings in the Netherlands against the Dutch part of this patent. Instead of providing arguments against the nullity attacks, Dürr Dental said that it had been, and still was, willing to withdraw the Dutch part of the patent. However, due to the pending proceedings, withdrawal of the patent was not possible anymore without the consent of Acteon. Acteon refused to give this. On the basis of this alleged lack of collaboration on the part of Acteon, Dürr Dental argued that Acteon had to bear the costs of the proceedings, brought without a preliminary warning and considered avoidable by Dürr Dental, and that Article 1019h Rv was not applicable in this case.

As a reminder, Article 1019h Rv provides for a reimbursement of costs by the losing party in IP cases. However, case law stipulates that this is not valid for nullity proceedings, except if the nullity proceedings are a defence against an infringement action or can be considered as a prospective defence of non-infringement.

In the absence of a defence, the Court revoked the Dutch part of the patent. With respect to the argument that the proceedings could have been avoided if Acteon had preliminarily warned Dürr Dental, the Court pointed to the fact that Dürr Dental had been paying annuities for several years to maintain the Dutch part of the patent. At the same time, the Court was of the opinion that in light of the infringement proceedings instituted by Dürr Dental in Germany, Acteon had rightfully started the Dutch nullity proceedings as a prospective defence of non-infringement. However, as Dürr Dental had immediately indicated that it did not wish to defend the Dutch part of its European patent, the Court ruled that only the costs incurred by Acteon until the writ was served, were to be borne by Dürr Dental.

Thus, even if a patentee indicates that it does not wish to exercise its patent rights, it can still be ordered to pay the costs of the proceedings.

Eva Eulaers

V.O.

Carnegieplein 5, 2517 KJ

The Hague

The Netherlands

Tel: +31 70 416 67 11

Fax: +31 70 416 67 99

info@vo.eu

www.vo.eu

more from across site and ros bottom lb

More from across our site

Partners and other senior leaders must step up if they want diverse talent at their firms to thrive
European and US counsel reveal why they are (or aren't) concerned about patent quality and explain how external counsel can help
Firms such as Bird & Bird and Taylor Wessing have reported rising profits and highlighted the role of high-profile IP disputes and hires
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Lawyers in the corporate and IP practices discuss where the firm can steal a march on competitors, its growth plans in London, and why deal lawyers are ‘concertmasters’
Kathleen Gaynor, DEI specialist at Phillips Ormonde Fitzpatrick, says deliberate actions can help law firms reach diversity goals
Scott McKeown, who moved to Wolf Greenfield one year ago, says the change has helped him tap into life sciences work and advise more patent owners
The winners of our Asia-Pacific Awards 2024 will be revealed during a ceremony in Malaysia on September 26
Zach Piccolomini of Wolf Greenfield explains how to maximise your IP portfolio’s value while keeping an eye on competitors
Witnesses at a Congressional hearing debated whether reforming the ITC is necessary and considered what any changes should look like
Gift this article